CompletedNCT01195363
Quetiapine Added to Mood Stabilizers for Mixed Bipolarity Symptoms
About this title
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
Read the official source — NCT01195363Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- San AntonioSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 28
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01195363
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Did this study involve medication?
Yes. The study involved medication, including quetiapine SR and quetiapine sr placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
